These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 16084850

  • 1. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
    Backman JT, Luurila H, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 Aug; 78(2):154-67. PubMed ID: 16084850
    [Abstract] [Full Text] [Related]

  • 2. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
    Lilja JJ, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065
    [Abstract] [Full Text] [Related]

  • 3. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
    Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P.
    Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
    [Abstract] [Full Text] [Related]

  • 4. Gemfibrozil greatly increases plasma concentrations of cerivastatin.
    Backman JT, Kyrklund C, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2002 Dec; 72(6):685-91. PubMed ID: 12496749
    [Abstract] [Full Text] [Related]

  • 5. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
    Schneck DW, Birmingham BK, Zalikowski JA, Mitchell PD, Wang Y, Martin PD, Lasseter KC, Brown CD, Windass AS, Raza A.
    Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058
    [Abstract] [Full Text] [Related]

  • 6. Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin.
    Whitfield LR, Porcari AR, Alvey C, Abel R, Bullen W, Hartman D.
    J Clin Pharmacol; 2011 Mar; 51(3):378-88. PubMed ID: 20413454
    [Abstract] [Full Text] [Related]

  • 7. Erythromycin coadministration increases plasma atorvastatin concentrations.
    Siedlik PH, Olson SC, Yang BB, Stern RH.
    J Clin Pharmacol; 1999 May; 39(5):501-4. PubMed ID: 10234598
    [Abstract] [Full Text] [Related]

  • 8. Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.
    Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2003 Jun; 73(6):538-44. PubMed ID: 12811363
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simultaneous quantification of atorvastatin and active metabolites in human plasma by liquid chromatography-tandem mass spectrometry using rosuvastatin as internal standard.
    Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Boosi R, Anjaneyulu Y.
    Biomed Chromatogr; 2006 Sep; 20(9):924-36. PubMed ID: 16470513
    [Abstract] [Full Text] [Related]

  • 11. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.
    Cilla DD, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL.
    Clin Pharmacol Ther; 1996 Dec; 60(6):687-95. PubMed ID: 8988072
    [Abstract] [Full Text] [Related]

  • 12. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [Abstract] [Full Text] [Related]

  • 13. Plasma concentrations of active simvastatin acid are increased by gemfibrozil.
    Backman JT, Kyrklund C, Kivistö KT, Wang JS, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Aug; 68(2):122-9. PubMed ID: 10976543
    [Abstract] [Full Text] [Related]

  • 14. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R, Williams RX, Guha-Ray DK, Sawyers WG, Braun SL, Rains KT.
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [Abstract] [Full Text] [Related]

  • 15. Effect of itraconazole on the pharmacokinetics of atorvastatin.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1998 Jul; 64(1):58-65. PubMed ID: 9695720
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY, Okochi H, Huang Y, Benet LZ.
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [Abstract] [Full Text] [Related]

  • 17. Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone.
    Niemi M, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2004 Sep; 76(3):239-49. PubMed ID: 15371985
    [Abstract] [Full Text] [Related]

  • 18. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
    Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
    [Abstract] [Full Text] [Related]

  • 19. No pharmacokinetic or pharmacodynamic interaction between atorvastatin and the oral direct thrombin inhibitor ximelagatran.
    Sarich TC, Schützer KM, Dorani H, Wall U, Kalies I, Ohlsson L, Eriksson UG.
    J Clin Pharmacol; 2004 Aug; 44(8):928-34. PubMed ID: 15286097
    [Abstract] [Full Text] [Related]

  • 20. Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS.
    Hermann M, Christensen H, Reubsaet JL.
    Anal Bioanal Chem; 2005 Jul; 382(5):1242-9. PubMed ID: 15933849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.